| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (586kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-452406
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.45240
Zusammenfassung
Background: The role of venovenous extracorporeal membrane oxygenation (VV ECMO) in patients with COVID-19-induced acute respiratory distress syndrome (ARDS) still remains unclear. Our aim was to investigate the clinical course and outcome of those patients and to identify factors associated with the need for prolonged ECMO therapy. Methods: A retrospective single-center study on patients with VV ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags